BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38588920)

  • 21. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
    Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
    Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.
    Weber DC; Schneider R; Goitein G; Koch T; Ares C; Geismar JH; Schertler A; Bolsi A; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):865-71. PubMed ID: 22138457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
    Brown DA; Goyal A; Kerezoudis P; Alvi MA; Himes BT; Bydon M; Van Gompel JJ; Chaichana KL; Quiñones-Hinojosa A; Burns TC; Yan E; Parney IF
    J Neurooncol; 2020 Sep; 149(2):293-303. PubMed ID: 32860156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis.
    Roesch J; Oertel M; Wegen S; Trommer M; Schleifenbaum J; Hering D; Mäurer M; Knippen S; Dobiasch S; Waltenberger M; von der Grün J; Medenwald D; Süß C; Hoeck M; Käsmann L; Fleischmann DF; Rühle A; Nicolay NH; Fabian A; Löser A; Heß S; Tamaskovics B; Vinsensia M; Hecht M;
    Radiother Oncol; 2023 Apr; 181():109380. PubMed ID: 36273736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of WHO Grade 2 Meningiomas With Stereotactic Radiosurgery: Identification of an Optimal Group for SRS Using RPA.
    Kowalchuk RO; Shepard MJ; Sheehan K; Sheehan D; Faramand A; Niranjan A; Kano H; Gurewitz J; Bernstein K; Liscak R; Guseynova K; Grills IS; Parzen JS; Cifarelli CP; Rehman AA; Atik A; Bakhsheshian J; Zada G; Chang E; Giannotta S; Speckter H; Wu HM; Kondziolka D; Mathieu D; Lee CC; Warnick RE; Lunsford LD; Trifiletti DM; Sheehan JP
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):804-814. PubMed ID: 33548341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.
    Detti B; Scoccianti S; Di Cataldo V; Monteleone E; Cipressi S; Bordi L; Pellicanò G; Gadda D; Saieva C; Greto D; Pecchioli G; Buccoliero A; Ceroti M; Ammannati F; Biti G
    J Neurooncol; 2013 Dec; 115(3):421-7. PubMed ID: 24045968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
    Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WHO grade II and III meningiomas: a study of prognostic factors.
    Durand A; Labrousse F; Jouvet A; Bauchet L; Kalamaridès M; Menei P; Deruty R; Moreau JJ; Fèvre-Montange M; Guyotat J
    J Neurooncol; 2009 Dec; 95(3):367-375. PubMed ID: 19562258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
    Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
    Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.
    Biczok A; Jungk C; Egensperger R; von Deimling A; Suchorska B; Tonn JC; Herold-Mende C; Schichor C
    J Neurooncol; 2019 Dec; 145(3):469-477. PubMed ID: 31713016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
    Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
    Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
    Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors.
    Buglione M; Maddalo M; Mazzeo E; Bonomo P; Spiazzi L; Bruni A; Paiar F; Triggiani L; Greto D; Rubino L; Livi L; Bertoni F; Magrini SM
    Tumori; 2015; 101(5):585-92. PubMed ID: 26108237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.
    Agas RAF; Yu KKL; Sogono PG; Co LBA; Jacinto JCKM; Bacorro WR; Mejia MBA
    J Glob Oncol; 2019 Feb; 5():1-14. PubMed ID: 30735433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
    Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
    Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
    Mooney MA; Bi WL; Cantalino JM; Wu KC; Harris TC; Possatti LL; Juvekar P; Hsu L; Dunn IF; Al-Mefty O; Devlin PM
    J Neurooncol; 2020 Jan; 146(1):111-120. PubMed ID: 31745706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma.
    Kaul D; Budach V; Wurm R; Gruen A; Graaf L; Habbel P; Badakhshi H
    Radiat Oncol; 2014 Mar; 9():78. PubMed ID: 24650090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
    Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
    Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
    Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.
    Valery CA; Faillot M; Lamproglou I; Golmard JL; Jenny C; Peyre M; Mokhtari K; Mazeron JJ; Cornu P; Kalamarides M
    J Neurosurg; 2016 Dec; 125(Suppl 1):89-96. PubMed ID: 27903189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.